ARCT-2138 (LUNAR-FLU) Phase 1 topline immunogenicity and safety data, anticipated in Q3 ARCT-810 (LUNAR-OTC) Phase 2 and ARCT-032 (LUNAR-CF) Phase 1b interim data and update to be provided on July 1 ...
Dr Tedros Adhanom Ghebreyesus said 'the virus is still changing and is still capable of causing new waves of diseases and death'. (AFP via Getty Images) The leader of the World Health Organization ...
CEO and President Joe Payne outlined the company’s current focus on messenger RNA (mRNA) therapeutics, emphasizing a leaner ...
A new Covid strain behind a surge of infections in India has sparked fears it could also lead to a rise in cases in the UK. Research indicates Arcturus could be one 1.2 times more infectious than the ...
The Arcturus COVID-19 variant has arrived in the United States and is here to stay, according to experts. While it's unclear whether it will drive a summer surge, some doctors are warning that the ...
Arcturus Therapeutics Holdings (ARCT) is set to present at the 44th Annual J.P. Morgan Healthcare Conference on January 12, ...
SAN DIEGO--(BUSINESS WIRE)--Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a global messenger RNA medicines company focused on the development of infectious disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results